Panache Ventures
Panache Ventures
Type of Funding
Venture Capital
Max Funding
N/A
Region
Federal/National
Application Difficuty
Fairly simple
Processing Time
Slow (A few months)
Province
All Of Canada
Industry
Other.
Funding Goals
Start-up Funding.
Demographic
N/A
Incorporated
No
Contact
info@panache.vc
Apply For A Loan
Business location – Canada
Monthly Revenue – $10K +
Time in Business – 6 months +
Funds in 24 hours
$10,000 to $800,000
Details
Panache Ventures is a venture capital firm specializing in seed stage startup investments. It seeks to invest in artificial intelligence (AI), cybersecurity, blockchain, virtual reality (VR), enterprise SaaS, and data analytics across Canada.
It is founded January 6, 2018. It has its headquarters in Calgary in Canada with an additional office in Montreal and Toronto therein.
Eligibility
Seed Stage Startups
Similar funding programs
Venture Capital
7 Gate Ventures is a venture capital firm based in Vancouver, Canada and Silicon Valley, investing in early-stage startups from Seed to pre-Series A in the Technology industry, with a sector focus on Software, SaaS, Cloud Services, Marketplaces, Mobile Apps and Solutions, Big Data/Analytics, Blockchain, Fintec, and HealthTech.
Max Funding N/A
7 Gate Ventures
Venture Capital
OnWave Ventures is an early to growth stage venture fund focused on investing in Fintech, mobile, and internet technology.
They seek to deploy between C$100K - C$1MM per investment in early stages, with capital reserved for follow-on opportunities with successful ventures.
Their primary geographic focus is Canada and the USA.
Theirr approach is to act as an enabler, providing the support, resources, and discipline that help great ideas to blossom into meaningful enterprises.
They invest our own capital which allows us to take a long-term view and provide flexibility around structure, term and dynamics.
Max Funding N/A
OnWave Ventures
Venture Capital
Based in Montréal, CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S.
CTI Life Sciences currently manage $245 million of assets.
Max Funding N/A
CTI Life Sciences